AI-generated analysis. Always verify with the original filing.
Sana Biotechnology, Inc. announced the appointment of Brian Piper as Executive Vice President, Chief Financial Officer, and Treasurer effective February 17, 2026, succeeding Steven D. Harr, M.D., as Principal Financial Officer. Mr. Piper's offer letter provides a $515,000 base salary, 40% target bonus, options for 900,000 shares, and 200,000 RSUs.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment o
, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilitie
Financial Statements and Exhibits. (d) Exhibits See the Exhibit Index below, which is incorporated by reference herein. EXHIBIT INDEX Exhibit Number Description
Brian Piper
Effective: 2026-02-17
Steven D. Harr, M.D.
Effective: Immediately prior to 2026-02-17
Transition to new appointee